Dr. Conklin studies ways to improve patient care and outcomes across different settings. His research includes using virtual reality technology to enhance training for caregivers of dementia patients, helping them gain empathy and knowledge about the disease. He also explores respiratory illnesses in animals, identifying pathogens that cause infections in dogs, cats, and horses. Additionally, he investigates the effectiveness of treatments against infections in humans, particularly concerning fungal diseases and the use of healthcare policies like the Affordable Care Act to improve cancer care.
Key findings
Virtual reality training for dementia caregivers improves empathy and knowledge, helping them provide better care.
In a study of nearly 1,900 tests on animals, 66% of dog cases tested positive for Mycoplasma cynos, while 60% of cat cases showed Mycoplasma felis.
Older adults in long-term care facilities showed 26.1% improved life satisfaction linked to time spent with staff and quality of their living environment.
In dogs treated for Brucella canis, a 40% decrease in specific antibody levels after 2-6 months indicated effective monitoring could improve treatment outcomes.
After the Affordable Care Act's implementation, patients had more imaging tests and fewer late-stage diagnoses, improving breast cancer care.
Frequently asked questions
Does Dr. Conklin study dementia?
Yes, he researches how virtual reality can train caregivers for dementia patients.
What treatments has Dr. Conklin researched for fungal infections?
He has studied various antifungal medications and their effectiveness against infections in both humans and animals.
Is Dr. Conklin's work relevant to animal health?
Absolutely, he has published extensive research on respiratory infections in pets, which is beneficial for veterinarians and pet owners.
How has Dr. Conklin contributed to cancer care?
He has analyzed the impact of the Affordable Care Act on breast cancer treatment, noting improved patient outcomes.
What insights does Dr. Conklin have for older adults in care facilities?
His research identifies factors that contribute to life satisfaction, helping enhance the quality of life for residents.
Publications in plain English
Mapping the evidence on virtual reality for dementia caregivers: a scoping review.
2026
Health education research
Li X, Li Q, Sun K, Conklin R
Plain English This study looked at how virtual reality (VR) can help train caregivers for people with dementia. It examined 17 different studies and found that VR effectively improves caregivers' empathy and knowledge about dementia, making them better prepared to provide care. However, there are still some issues with the way studies were conducted, which means more research is needed to find the best ways to use VR in caregiver training.
Who this helps: This helps caregivers, including family members and healthcare professionals, improve their skills in caring for dementia patients.
Personal and Organizational Factors as Predictors of Life Satisfaction Among Older Adults in Long-Term Care Settings.
2025
Healthcare (Basel, Switzerland)
Li X, Yin C, Abude-Aribo JO, Conklin R, Mpofu E
Plain English This study looked at what factors influence the happiness of older adults living in long-term care facilities in China. Researchers found that personal factors such as age and independence, along with care service aspects like the time spent with staff and the living environment, explained about 26.1% of how satisfied residents felt. For example, spending more time with staff and having a good environment predicted higher satisfaction levels, particularly for residents aged 70-79.
Who this helps: This helps patients in long-term care facilities by highlighting ways to improve their overall satisfaction with care.
A retrospective analysis of canine, feline, and equine respiratory polymerase chain reaction panels performed at the New York State Animal Health Diagnostic Center (January-December 2023).
2025
Journal of the American Veterinary Medical Association
Snedden K, Frye E, Conklin R, Aprea M, Rishniw M +2 more
Plain English This study looked at the results of respiratory tests for dogs, cats, and horses conducted at an animal health center in New York during 2023. Out of nearly 1,900 tests, the most common pathogens found were bacteria and viruses, with 66% of dog cases showing Mycoplasma cynos, and 60% of cat cases showing Mycoplasma felis. Acute cases were more likely to test positive than chronic cases, and the study emphasized that when samples are collected early during illness, they are more likely to provide accurate results.
Who this helps: This benefits veterinarians and pet owners by improving diagnosis and treatment of respiratory infections in their animals.
Antibody response over time correlated with treatment outcome in 30 dogs naturally infected with Brucella canis (2017-2022).
2023
American journal of veterinary research
Guarino C, Franklin-Guild R, Goodrich E, Conklin R, Frye E +1 more
Plain English This study looked at 30 dogs infected with Brucella canis, a bacteria that can spread to humans and is hard to treat. The researchers found that dogs receiving treatment showed a significant decrease of 40% in specific antibody levels after 2 to 6 months if their symptoms improved, indicating that monitoring these antibody levels can be helpful. Understanding how to effectively treat and monitor these infections is important for better outcomes in both dogs and their human families.
Who this helps: This helps pet owners, veterinarians, and public health officials.
Polyanion order controls liquid-to-solid phase transition in peptide/nucleic acid co-assembly.
2022
Frontiers in molecular biosciences
Gordon-Kim C, Rha A, Poppitz GA, Smith-Carpenter J, Luu R +4 more
Plain English This study focused on how certain structures of nucleic acids (like DNA) influence the transformation of a specific Alzheimer's-related peptide from a liquid state to a solid state. Researchers found that more organized phosphate structures, such as double-stranded DNA, can significantly affect this transition. Understanding these processes is important because they could help in developing treatments for diseases where the aggregation of proteins, like in Alzheimer's, is problematic.
Who this helps: Patients with neurodegenerative diseases like Alzheimer's.
The impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.
2019
The breast journal
Maxwell J, Shats O, Aldridge J, Lyden E, Krie A +12 more
Plain English This study looked at how the Affordable Care Act (ACA) affected breast cancer care in the United States by comparing data from hospitals before and after its implementation. After the ACA was enacted, patients tended to be older and more likely to have Medicaid insurance. Notably, there was a rise in imaging tests performed, which led to more patients being diagnosed at earlier stages of cancer, resulting in fewer mastectomies and more patients receiving radiation treatment.
Who this helps: This benefits breast cancer patients and healthcare providers.
A peer-driven mentoring case management community reentry model: an application for jails and prisons.
2009
Family & community health
Goldstein EH, Warner-Robbins C, McClean C, Macatula L, Conklin R
Plain English This study looked at a program called Welcome Home Ministries that helps women leave jail and prison and reintegrate into their communities. Researchers found that 85% of the women in the program had experienced both mental health issues and substance abuse, often linked to trauma from their childhood. The program not only helps these women recover but also encourages them to contribute back to their communities, which is important for reducing repeat offenses and supporting their transition.
Who this helps: This benefits women leaving incarceration, as well as their communities.
Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
2006
Antimicrobial agents and chemotherapy
Andes D, Safdar N, Marchillo K, Conklin R
Plain English This study looked at three forms of amphotericin B, an antifungal medication, to see how effective they are against a type of infection called candidiasis in mice. The researchers found that the traditional form of amphotericin B was 4.3 to 5.9 times more effective than two lipid-based versions (liposomal amphotericin B and amphotericin B lipid complex) in reducing fungal levels in the kidneys. This is important because it shows that while lipid formulations are often used, they may not work as well as the standard form, highlighting the need for careful treatment choices in patients with fungal infections.
Who this helps: Patients with fungal infections.
Plain English This study tested how effective two different doses of a medication called octreotide are at preventing severe diarrhea caused by chemotherapy. Among 124 patients, those receiving the higher dose of 40 mg had slightly fewer incidents of severe diarrhea (48.4%) compared to those on the 30 mg dose (61.7%), but these results were not statistically significant enough to make firm conclusions. This is important because managing diarrhea can improve patients' chemotherapy experience and adherence to their treatment plans.
Who this helps: Patients undergoing chemotherapy.
Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis.
2004
Antimicrobial agents and chemotherapy
Andes D, Marchillo K, Conklin R, Krishna G, Ezzet F +2 more
Plain English This study examined how well a new antifungal medicine called posaconazole works against a kind of yeast infection in mice that have weakened immune systems. Researchers found that the effectiveness of posaconazole is linked to how much of the drug is in the bloodstream over time, specifically a measure called the AUC/MIC ratio. They discovered that this ratio ranged from 6.12 to 26.7, with an average of 16.9, indicating that posaconazole performs comparably to existing treatments.
Who this helps: This benefits patients with serious yeast infections, especially those with weakened immune systems.
In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.
2003
Antimicrobial agents and chemotherapy
Andes D, Marchillo K, Lowther J, Bryskier A, Stamstad T +1 more
Plain English This study explored how well a new antifungal drug called HMR 3270 works in mice with a severe yeast infection. Researchers found that higher doses of the drug lead to better results, specifically that a concentration more than four times above the minimum effective level killed the fungus effectively and prolonged its effects for up to 80 hours. Understanding the right dose and how the drug works helps improve treatment for patients with serious fungal infections.
Who this helps: This helps patients with severe yeast infections, particularly those who are immunocompromised.
In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model.
2003
Antimicrobial agents and chemotherapy
Andes D, Marchillo K, Stamstad T, Conklin R
Plain English This study looked at a new antifungal drug called ravuconazole to see how well it works against a type of yeast infection in mice. Researchers found that ravuconazole had a chemical ratio (called the AUC/MIC ratio) that was predictive of treatment success, showing numbers between 10 and 36, with an average of 20.3. This is important because it demonstrates that ravuconazole can be as effective as the existing antifungal fluconazole, which helps in developing new treatments for serious fungal infections.
Who this helps: This helps patients with fungal infections, particularly those at higher risk due to weakened immune systems.
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
2003
Antimicrobial agents and chemotherapy
Andes D, Marchillo K, Stamstad T, Conklin R
Plain English This study looked at how well a new antifungal drug called voriconazole works against a yeast infection in mice that have weakened immune systems. Researchers found that a specific measurement, called the AUC/MIC ratio, was a strong indicator of how effective the treatment would be, with ratios ranging from 11 to 58 and an average of 24. This information is important because it helps determine the right dosage of voriconazole needed to effectively treat similar infections in humans.
Who this helps: This helps doctors determining treatment plans for patients with serious yeast infections.
Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
2001
Antimicrobial agents and chemotherapy
Andes D, Stamsted T, Conklin R
Plain English This study looked at how well the antifungal drug amphotericin B works in treating a fungal infection in mice with weakened immune systems. Researchers found that giving larger doses of the drug in a single administration was much more effective, requiring 4.8 to 7.6 times less total drug to achieve the same results compared to spreading it out over several doses. This is important because it highlights the need to rethink how amphotericin B is prescribed to improve treatment outcomes for patients who have serious fungal infections.
Who this helps: This helps patients with serious fungal infections and doctors who treat them.
A comparison of the effects of isoproterenol and forskolin on immunologic and nonimmunologic release of histamine from guinea-pig superfused trachea and dispersed tracheal cells.
1995
Journal of pharmacological and toxicological methods
Buckner CK, Fishleder RI, Conklin R, Graziano FM
Plain English This study looked at the effects of two substances, isoproterenol and forskolin, on the release of histamine from trachea (the windpipe) in guinea pigs. Isoproterenol was found to be effective in preventing histamine release triggered by a specific immune response, while forskolin was less effective in this regard. The significance of these findings lies in the potential for better understanding how to control inflammation and airway constriction, which may help in treating respiratory conditions.
Who this helps: This benefits patients with asthma and other respiratory diseases.
Pharmacologic modulation of the influence of the epithelium on immunologic- and nonimmunologic-induced histamine release and contraction in guinea pig superfused tracheal strips.
1993
The Journal of pharmacology and experimental therapeutics
Buckner CK, Fishleder RI, Conklin R, Will JA, Doran O +1 more
Plain English This study looked at how the cells lining the airways (the epithelium) affect the release of histamine and airway contractions in guinea pigs. It found that when the epithelium was removed, the total histamine released increased significantly—by about 15%—in response to a specific allergen (ovalbumin) or a muscle relaxant (d-tubocurarine). The results are important because they help explain how airway responses in conditions like asthma could be influenced by the lung's epithelial cells, which may impact treatment strategies.
Who this helps: This helps patients with asthma or other respiratory conditions.
Studies of desensitization and cross-desensitization to immunologic and nonimmunologic stimuli that evoke contraction and histamine release in superfused guinea pig trachea.
1991
The Journal of allergy and clinical immunology
Buckner CK, Ro J, Brendel J, Fishleder RI, Will JA +2 more
Plain English This study looked at how different triggers, both immune-related and non-immune, affect contraction and the release of histamine in guinea pig tracheas (the airways). Researchers found that certain substances like compound 48/80 and D-tubocurarine could cause desensitization, meaning that prior exposure reduced the reaction to these triggers. However, the study showed that there isn't a strong connection in the way the airway reacts to immune and non-immune triggers, suggesting separate mechanisms at work.
Who this helps: This helps researchers and doctors understand airway responses better, which could impact treatments for respiratory conditions.
Transplantation of adrenal medullary tissue to caudate nucleus using stereotactic techniques.
1990
Stereotactic and functional neurosurgery
Gildenberg PL, Pettigrew LC, Merrell R, Butler I, Conklin R +2 more
Plain English This study looked at the effects of transplanting adrenal medullary tissue into the brain of 12 patients with Parkinson's disease using a precise surgical method. The results showed that all patients initially felt better, and 11 out of the 12 patients continued to experience improvements six to eighteen months later. Specifically, overall movement abilities improved significantly, with scores moving from an average of 59.2 to 75.8, and disease severity ratings improving from 3.42 to 2.92.
Who this helps: This benefits patients with Parkinson's disease seeking better symptom management.
Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts.
1989
Blood
Tomer A, Friese P, Conklin R, Bales W, Archer L +2 more
Plain English This study looked at blood cell types called megakaryocytes in patients with abnormal platelet counts compared to healthy individuals. The researchers found that patients with low platelet counts (thrombocytopenia) tended to have smaller cells and different levels of cell types, specifically an increase in lower ploidy cells, while patients with high platelet counts (thrombocytosis) had larger cells with more high ploidy cells. This information is important because it can help doctors understand whether a patient's problem is due to not enough platelets being produced or if the platelets are being destroyed too quickly.
Who this helps: This helps patients with platelet disorders and their doctors by providing better diagnostic tools.
Renal function studies during intravenous acyclovir treatment of immune suppressed patients including renal transplantation.
1988
American journal of nephrology
Kumor K, Conklin R, Woo J, Katz L, Strocchia C
Plain English The study looked at how the medication acyclovir, used to treat herpesvirus infections, affects kidney function in patients with weakened immune systems, including those who have had kidney transplants. Out of 32 patients, there was no overall decline in kidney function during treatment; however, 2 patients experienced temporary kidney issues that resolved after stopping acyclovir. This finding is important because it shows that while most patients do not experience harm to their kidneys from this medication, a small number might need monitoring.
Who this helps: This helps patients receiving acyclovir treatment, especially those with weakened immune systems.
Rotavirus antibody in chickens as measured by enzyme-linked immunosorbent blocking assay.
1980
American journal of veterinary research
Bartz CR, Conklin R, Steele JH, Glass SE
Plain English Researchers looked at how many chickens had antibodies against a specific rotavirus by testing samples from 202 birds across 15 flocks on six different farms. They found that 43% of the chickens tested positive for the virus, with infection rates varying widely from 0% to 90% among flocks, suggesting that the virus does not often spread between different flocks. This information matters because it helps understand how such infections might be managed better on farms, especially since the differences in infection rates might indicate that farm management plays a key role.
Who this helps: This helps farmers and veterinary professionals optimize health management practices for chickens.
N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice.
Plain English This study looked at data from 334 patients with myeloma, a type of cancer affecting plasma cells. They found that 7% of the patients had a localized form of myeloma and did not need chemotherapy, showing signs of disease progression in about one third of them within a year. Additionally, most patients with abnormal protein peaks in their blood had low levels of a specific type of immunoglobulin, and the researchers recommend tests to better understand these early stages of the disease.
Who this helps: This research benefits patients with myeloma, doctors treating them, and specialists who diagnose and monitor the disease.